October 02, 2014 11:41 AM ET

Healthcare Equipment and Supplies

Company Overview of PharmaJet, Inc.

Executive Profile

James A. Bowman

President and Chief Operating officer, PharmaJet, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
57--

Background

Mr. James A. Bowman, Jim served as President and Chief Executive Officer of Encision Inc. from February 2000 to June 25, 2004 and served as its Chairman of Board until June 2004. Mr. Bowman served as the Chief Executive Officer of Tissue Genetics Inc. a predictive medicine company with patented technology for diagnosing genetic diseases. Mr. Bowman has previously held various Director and management positions within the medical & surgical device industry, including C. ...

Corporate Headquarters

400 Corporate Circle
Golden, Colorado 80401

United States

Phone: 303-526-4278
Fax: 303-526-4052

Board Members Memberships

Director
2000-N/A
Former Director

Education

Unknown/Other Education
Harvard Business School
BS
Marquette University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PharmaJet, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.